1. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview
- Author
-
de Castro, Karine Cappuccio, Coco, Julia Cedran, dos Santos, Érica Mendes, Ataide, Janaína Artem, Martinez, Renata Miliani, do Nascimento, Mônica Helena Monteiro, Prata, João, Fonte, Pedro, Severino, Patrícia, Mazzola, Priscila Gava, Baby, André Rolim, Souto, Eliana Barbosa, de Araujo, Daniele Ribeiro, and Lopes, André Moreni
- Subjects
Amphiphilic copolymers ,Drug delivery systems (DDS) ,Pluronic? ,Cancer therapy ,Pharmaceutical Science ,Self-assembly ,Nanostructures (NSs) ,RADIOTERAPIA - Abstract
This paper provides a review of the literature on the use of Pluronic (R) triblock copolymers for drug encapsulation over the last 10 years. A special focus is given to the progress of drug delivery systems (e.g., micelles, liposomes, micro/nanoemulsions, hydrogels and nanogels, and polymersomes and niosomes); the beneficial aspects of Pluronic (R) triblock copolymers as biological response modifiers and as pharmaceutical additives, adjuvants, and stabilizers, are also discussed. The advantages and limitations encountered in developing site-specific targeting approaches based on Pluronic-based nanostructures in cancer treatment are highlighted, in addition to inno-vative examples for improving tumor cytotoxicity while reducing side effects. info:eu-repo/semantics/publishedVersion
- Published
- 2022